
Please try another search
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Name | Age | Since | Title |
---|---|---|---|
Richard A. B. Stewart | 66 | 2017 | CEO & Executive Director |
Thomas Sellig | 58 | 2023 | Independent Director |
Thomas B. King | 70 | 2023 | Independent Chairman |
Kristen Belmonte Slaoui | 54 | 2025 | Independent Director |
Bridget Ann Martell | 59 | 2021 | Independent Director |
Nancy R. Phelan | 56 | 2025 | Independent Director |
Stuart M. Duty | 60 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review